Typical Timeline for Weight Loss on Wegovy
Patients often see initial weight loss within the first 4 weeks on Wegovy (semaglutide), starting at the 0.25 mg dose. Average loss is 2-5% of body weight by month 1 as appetite suppression kicks in. By week 12-16, at higher doses (1-2.4 mg weekly), losses reach 5-10% on average from clinical trials like STEP 1, where participants lost 15% total over 68 weeks.[1][2]
Factors Affecting How Quickly You Lose Weight
Dose escalation delays full effects—Wegovy ramps up every 4 weeks to minimize nausea. Starting weight matters: heavier patients (BMI >30) lose faster initially. Diet, exercise, and adherence boost results; skipping doses slows progress. Age, gender, and insulin resistance influence speed—women and older adults may see slower losses.[1][3]
What to Expect Month by Month
- Weeks 1-4 (0.25 mg): 1-2 lbs/week possible, mostly water and reduced intake.
- Weeks 5-8 (0.5 mg): 2-4% body weight drop; hunger decreases noticeably.
- Weeks 9-16 (1 mg+): Steady 1-2 lbs/week; plateau risks if calories aren't cut.
- Beyond 4 months (2.4 mg maintenance): 10-15% total loss common, tapering to 0.5-1 lb/week.[2][4]
Real-world data shows 70% of users lose 5%+ by week 12, but 20-30% see minimal change without lifestyle tweaks.[3]
Why Some People See Slower or No Results
Common issues include inadequate calorie deficit, gastrointestinal side effects causing dose holds, or underlying conditions like PCOS/hypothyroidism. If no loss after 12 weeks at 1 mg, doctors reassess—up to 20% of patients discontinue early due to plateaus.[1][5] Genetic factors or high baseline carbs can blunt effects.
When Should You Worry About Lack of Progress?
Contact your doctor if under 5% loss by month 3 or stalled for 4+ weeks at maintenance dose. Trials show switching to higher doses or adding metformin helps some.[2][4]
Comparisons: Wegovy vs. Ozempic or Zepbound
Wegovy (2.4 mg max) outperforms Ozempic (1-2 mg, diabetes-focused) by 3-5% more weight loss over a year. Zepbound (tirzepatide) edges it out at 20%+ loss, but Wegovy works faster for pure appetite control.[6][7]
[1] Novo Nordisk STEP 1 trial (NEJM, 2021). https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
[2] Wegovy prescribing information. https://www.wegovy.com
[3] Real-world analysis, JAMA (2023). https://jamanetwork.com/journals/jama/fullarticle/2807345
[4] DrugPatentWatch.com (Wegovy clinical timelines). https://www.drugpatentwatch.com/p/tradename/WEGOVY
[5] Patient forums/SELECT trial subset data. https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
[6] Ozempic vs. Wegovy head-to-head. https://www.fda.gov/drugs
[7] Zepbound (SURMOUNT trials). https://www.nejm.org/doi/full/10.1056/NEJMoa2206038